M

Main Line Health

Biomedical research division advancing cancer science

Overview

Lankenau Institute for Medical Research (LIMR) is the research division of Main Line Health that conducts cancer and biomedical research and translates basic science into clinical applications. LIMR studies cell growth and cancer biology, develops discoveries in the lab, and collaborates to move findings into patient care within the health system. It differs from other research centers by its long history as one of the first U.S. cancer-focused institutes, its integration within a hospital-based health system, and its track record of translational research—turning lab findings into clinical therapies and practices. The institute aims to improve patient outcomes by turning basic science into usable medical treatments and interventions for cancer and related diseases.

Significant Headcount Growth

Work here?Claim your company

About Main Line Health

Simplify's Rating
Why Main Line Health is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

BiotechnologyHealthcare

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Lancaster, PA

Founded

1927

Get referred to Main Line Health

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • S&P assigned Main Line Health AA- bonds on November 5, 2026, citing strong credit.
  • Fiscal 2026 admissions rose to 69,042 from 63,087, showing durable demand.
  • Main Line Health added 72 physicians in fiscal 2026, with 50 more hires scheduled.

What critics are saying

  • The August 2026 Torregrossa whistleblower lawsuit exposes governance and surgical oversight failures.
  • S&P said first-quarter fiscal 2027 lagged budget from soft radiology, NICU, and trauma volumes.
  • An NLRB case filed September 8, 2026 alleges discriminatory discharge, signaling labor instability.

What makes Main Line Health unique

  • Lankenau Institute for Medical Research gives Main Line Health uncommon translational research depth.
  • Main Line Health’s 45.9% regional market share reflects entrenched Philadelphia suburban scale.
  • Epic Payer Platform integration with Independence Blue Cross strengthens payer-provider workflow connectivity.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Pension
  • 403(b) Retirement Plan
  • Unlimited Paid Time Off
  • Tuition Reimbursement
  • Wellness Program
  • Family Planning Benefits

Growth & Insights and Company News

6 month growth

8%

1 year growth

5%

2 year growth

5%
Main Line Health
Nov 2nd, 2026
Awards and recognitions: october 2026.

Awards and recognitions: october 2026. Monday, November 2, 2026 Main Line Health nursing leaders recognized at 27th annual Nightingale Awards of Pennsylvania gala. Two Main Line Health nursing leaders were recognized for their remarkable contributions to nursing excellence at the 27th Annual Nightingale Awards of Pennsylvania Gala. Elizabeth (Craig) Connelly, Senior Vice President and Chief Nursing Officer for Main Line Health, received the Nursing Administration - Senior Level/Executive Award. Amy Callahan, System Director of Nursing Education and Professional Practice, was named a finalist for Nursing Administration - Leader/Manager/Director. Their recognition reflects our ongoing commitment to nursing excellence and to providing safe, high-quality care for the patients and communities we serve. Healthgrades recognizes Lankenau Medical Center and Riddle Hospital. Lankenau Medical Center and Riddle Hospital rank among Pennsylvania's best in the Healthgrades Specialty State Ranking, according to Healthgrades. Healthgrades recognizes the top-ranked hospitals in each state that deliver superior patient outcomes across 19-plus service lines. System recognized in 2026 CHIME Digital Health Most Wired survey. Main Line Health has once again earned Digital Health Most Wired recognition from the College of Healthcare Information Management Executives (CHIME) for our excellence in healthcare technology. This achievement reflects our leadership in leveraging digital health to improve care delivery, patient outcomes and operational performance. Lankenau Medical Center achieves reaccreditation for radiation oncology services. Lankenau Medical Center has been reaccredited by the American Society for Radiation Oncology (ASTRO) through APEx - Accreditation Program for Excellence(R). APEx is an accreditation program developed by ASTRO that validates a radiation oncology facility's excellence in delivering safe, high-quality patient care. Main Line Health recognized with SailPoint customer Award. Main Line Health's Identity and Access Management team was named SailPoint's 2026 Identity Security Champion at the Americas at SailPoint Navigate in Austin, Texas. This recognition celebrates the team's continued commitment to advancing identity security, strengthening access governance and supporting the security of Main Line Health's workforce and critical systems. Six LIMR researchers ranked among Top 2% Scientists for 2026. Lankenau Institute for Medical Research (LIMR) is proud to announce that six members of its faculty appear on the Stanford/Elsevier Top 2% Scientists List for 2026. This prestigious list highlights the world's leading scientists who have made a substantial impact in their respective fields through their citation influence. The LIMR scientists, in descending order of their rankings, are Charles Antzelevitch, PhD; George Prendergast, PhD; Michael Ezekowitz, MD; Basel Ramlawi, MD; William Gray, MD; and Sunil Thomas, PhD. Drs. Ramlawi and Gray are newcomers to the rankings. Prestigious appointment for Dr. Dimitrios Magouliotis. LIMR is pleased to announce that Dimitrios Magouliotis, MD, PhD, MBA, MSc, has been appointed to the Adult Cardiac Database Task Force of the European Association for Cardio-Thoracic Surgery. The database consists of surgical interventions and enables surgical teams from participating cardiac hospitals to recognize the data and outcomes from their own hospital and draw comparable data analyses with other hospitals and countries. Rosangely Cruz-Rojas, DrPH, Vice President and Chief Belonging, Equity and Community Officer, featured at annual equity event. Rosangely Cruz-Rojas, DrPH, Vice President and Chief Belonging, Equity and Community Officer, was the keynote speaker at this year's Equity of Care event hosted by the American College of Healthcare Executives of Greater Philadelphia and the National Association of Health Services Executives, Delaware Valley Chapter. The fourth annual event took place at Lankenau Medical Center. Dr. Marisa Weiss adds board certifications in women's health. Marisa Weiss, MD, Director of Breast Radiation Oncology and Breast Health Outreach at Lankenau Medical Center, has added certifications in three fields closely tied to women's health: obesity medicine, lifestyle medicine and menopause care. The new credentials allow Dr. Weiss to address the full range of needs facing people with breast cancer or concerned about their risk. These include weight, metabolic health, nutrition, physical activity, sleep, stress and menopause symptoms.

PR Newswire
Nov 22nd, 2024
Independence Blue Cross Launches Epic Payer Platform To Transform Care Coordination And Boost Member Health Outcomes

PHILADELPHIA, Nov. 22, 2024 /PRNewswire/ -- Independence Blue Cross (IBX) is implementing the Epic Payer Platform with health systems and providers in its network to streamline data exchange, close gaps in care, and improve health outcomes for members. Epic Payer Platform is part of Epic, a global healthcare technology company. The platform helps facilitate data exchange and workflow processes for providers and health plans, giving them the insights they need to make care decisions while also saving them time. "We're excited about the implementation of Epic Payer Platform with Drexel Medicine, Jefferson Health, Main Line Health, and Penn Medicine being the first to join us in this transformation. We look forward to more of our health care partners signing on as well," said Michael Vennera, executive vice president and chief strategy, technology, and operations officer at Independence Blue Cross

Managed Healthcare Executive
Feb 16th, 2022
Lankenau Institute For Medical Research hired George Prendergast as president and CEO on Jan 1st 04'.

When George Prendergast was appointed president and CEO of the Lankenau Institute of Medical Research (LIMR) in 2004, he coined the term “acapreneurial” as a mashup for the model he wanted to implement — inventions and startup incubation alongside traditional academic goals of research, new knowledge and its validation.

Recently Posted Jobs

Sign up to get curated job recommendations

Main Line Health is Hiring for 343 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs